December 2020, Bangalore: (www.iq4i.com/) IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd. is a global consultancy firm that offers high-quality healthcare market research data. With the current surge in research and development in the medication for NASH global market, IQ4I has come forward with its own take on the whole development. While keeping a close eye on the whole situation and the latest updates, the firm is offering high-quality information that would prove to be really beneficial in the long run.

Talking specifically about the nash drug pipeline report, we would first need to discuss the NASH. NASH stands for non-alcoholic steatohepatitis which is a type of liver disease that develops with little to no consumption of alcohol. Commonly known as silent liver disease, it is a major liver disease that has been ailing millions of patients all over the globe. Patients infected by this disease would have fat deposition in the inner walls along with inflammation. It also leads to liver cell damage and scarring of the liver (also known as cirrhosis). The number of drugs in development for this disease is over 70 and none are approved until this point.

The market estimation for NASH drugs is expected to reach around $21,478 million by 2025. Growth in its demand can be due to a combination of factors such as the rise in demand for ideal therapeutics of NASH, the increase in the number of patients with the disease and of course due to the rising number of candidate drugs that are expected to be launched during this forecasted period. The awareness about this disease has been rising and better diagnosis and awareness among the patients would be useful in helping solve this silent liver disease.

Be it hospital pharmacy, retail pharmacy or online drug providers, everyone would need these medications (if approved) for supplying to the huge demand of patients. With no options for medication right now in regards to NASH, any approved medication would be highly anticipated and demanded in the pharmaceutical industry. Not only would it be profitable for the pharmaceutical manufacturing companies to join in but it would also be a good opportunity to grow one's brand in offering a medication that is demanded as well as needed in the market.

About the company: (www.iq4i.com/) IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd. is a leading global market research and consultancy firm which has a prime focus in sectors of biotechnology, healthcare IT, pharmaceuticals and medical devices. Their clients come from various fields and include top leading businesses, investment banks, researchers and even government agencies.